{
    "id": 2704,
    "fullName": "HEY1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "HEY1 over exp indicates an over expression of the Hey1 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 23462,
        "geneSymbol": "HEY1",
        "terms": [
            "HEY1",
            "BHLHb31",
            "CHF2",
            "HERP2",
            "HESR1",
            "hHRT1",
            "HRT-1",
            "NERP2",
            "OAF1"
        ]
    },
    "variant": "over exp",
    "createDate": "12/09/2014",
    "updateDate": "08/30/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1452,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, HEY1, HES1 and SOX9 over expression demonstrated an additive increase in the risk of death in colorectal cancer patients treated with Adrucil (fluorouracil) chemotherapy, but not untreated patients (PMID: 23900217).",
            "molecularProfile": {
                "id": 2524,
                "profileName": "HEY1 over exp"
            },
            "therapy": {
                "id": 1715,
                "therapyName": "Fluorouracil",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 1299,
                    "pubMedId": 23900217,
                    "title": "Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23900217"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 6938,
            "approvalStatus": "Clinical Study",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a clinical study, HEY1 over expression correlated with poor outcome in colorectal cancer patient (PMID: 23900217).",
            "molecularProfile": {
                "id": 2524,
                "profileName": "HEY1 over exp"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 1299,
                    "pubMedId": 23900217,
                    "title": "Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23900217"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 7143,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, GANT61 did not inhibit growth of primary liver cancer cells over expressing target genes of the Notch (HES1, HEY1, TRIB2, NOTCH3, CCND1) and Hedgehog (GLI1, GLI2) pathways in culture (PMID: 27103434).",
            "molecularProfile": {
                "id": 24497,
                "profileName": "CCND1 over exp GLI1 over exp GLI2 over exp HES1 over exp HEY1 over exp NOTCH3 over exp TRIB2 over exp"
            },
            "therapy": {
                "id": 1786,
                "therapyName": "GANT61",
                "synonyms": null
            },
            "indication": {
                "id": 3571,
                "name": "liver cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6106,
                    "pubMedId": 27103434,
                    "title": "The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27103434"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7144,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PNU-74654 did not inhibit growth of primary liver cancer cells over expressing target genes of the Notch (HES1, HEY1, TRIB2, NOTCH3, CCND1) and Hedgehog (GLI1, GLI2) pathways in culture (PMID: 27103434).",
            "molecularProfile": {
                "id": 24497,
                "profileName": "CCND1 over exp GLI1 over exp GLI2 over exp HES1 over exp HEY1 over exp NOTCH3 over exp TRIB2 over exp"
            },
            "therapy": {
                "id": 2454,
                "therapyName": "PNU-74654",
                "synonyms": null
            },
            "indication": {
                "id": 3571,
                "name": "liver cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6106,
                    "pubMedId": 27103434,
                    "title": "The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27103434"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7145,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Nutlin-3 moderately inhibited growth of primary liver cancer cells over expressing target genes of the Notch (HES1, HEY1, TRIB2, NOTCH3, CCND1) and Hedgehog (GLI1, GLI2) pathways in culture (PMID: 27103434).",
            "molecularProfile": {
                "id": 24497,
                "profileName": "CCND1 over exp GLI1 over exp GLI2 over exp HES1 over exp HEY1 over exp NOTCH3 over exp TRIB2 over exp"
            },
            "therapy": {
                "id": 1405,
                "therapyName": "Nutlin-3",
                "synonyms": null
            },
            "indication": {
                "id": 3571,
                "name": "liver cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 6106,
                    "pubMedId": 27103434,
                    "title": "The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27103434"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 7146,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, GSK2334470 moderately inhibited growth of primary liver cancer cells over expressing target genes of the Notch (HES1, HEY1, TRIB2, NOTCH3, CCND1) and Hedgehog (GLI1, GLI2) pathways in culture (PMID: 27103434).",
            "molecularProfile": {
                "id": 24497,
                "profileName": "CCND1 over exp GLI1 over exp GLI2 over exp HES1 over exp HEY1 over exp NOTCH3 over exp TRIB2 over exp"
            },
            "therapy": {
                "id": 3662,
                "therapyName": "GSK2334470",
                "synonyms": null
            },
            "indication": {
                "id": 3571,
                "name": "liver cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 6106,
                    "pubMedId": 27103434,
                    "title": "The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27103434"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 7147,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY3039478 and NSC156529 combination treatment resulted in improved growth inhibition over single drug treatment in primary liver cancer cells over expressing target genes of the Notch (HES1, HEY1, TRIB2, NOTCH3, CCND1) and Hedgehog (GLI1, GLI2) pathways in culture (PMID: 27103434).",
            "molecularProfile": {
                "id": 24497,
                "profileName": "CCND1 over exp GLI1 over exp GLI2 over exp HES1 over exp HEY1 over exp NOTCH3 over exp TRIB2 over exp"
            },
            "therapy": {
                "id": 4383,
                "therapyName": "LY3039478 + NSC156529",
                "synonyms": null
            },
            "indication": {
                "id": 3571,
                "name": "liver cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6106,
                    "pubMedId": 27103434,
                    "title": "The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27103434"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7142,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, NSC156529 efficiently inhibited survival of primary liver cancer cells over expressing target genes of the Notch (HES1, HEY1, TRIB2, NOTCH3, CCND1) and Hedgehog (GLI1, GLI2) pathways in culture (PMID: 27103434).",
            "molecularProfile": {
                "id": 24497,
                "profileName": "CCND1 over exp GLI1 over exp GLI2 over exp HES1 over exp HEY1 over exp NOTCH3 over exp TRIB2 over exp"
            },
            "therapy": {
                "id": 4085,
                "therapyName": "NSC156529",
                "synonyms": null
            },
            "indication": {
                "id": 3571,
                "name": "liver cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6106,
                    "pubMedId": 27103434,
                    "title": "The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27103434"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7141,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY3039478 efficiently inhibited survival of primary liver cancer cells over expressing target genes of the Notch (HES1, HEY1, TRIB2, NOTCH3, CCND1) and Hedgehog (GLI1, GLI2) pathways in culture (PMID: 27103434).",
            "molecularProfile": {
                "id": 24497,
                "profileName": "CCND1 over exp GLI1 over exp GLI2 over exp HES1 over exp HEY1 over exp NOTCH3 over exp TRIB2 over exp"
            },
            "therapy": {
                "id": 2958,
                "therapyName": "LY3039478",
                "synonyms": null
            },
            "indication": {
                "id": 3571,
                "name": "liver cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6106,
                    "pubMedId": 27103434,
                    "title": "The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27103434"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2524,
            "profileName": "HEY1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 2526,
            "profileName": "HES1 over exp HEY1 over exp SOX9 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 24497,
            "profileName": "CCND1 over exp GLI1 over exp GLI2 over exp HES1 over exp HEY1 over exp NOTCH3 over exp TRIB2 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}